Backed by Norwest.
About the role
Avalyn is seeking a highly collaborative, adaptable, and proactive Executive Assistant to support our General Counsel & Head of Business Development and to work as part of a team of Executive Assistants providing support to senior leaders as needed. This is an exciting opportunity to join the company during a pivotal stage following our recent IPO.
What they're looking for
- Minimum of 8+ years of relevant executive support experience, with the demonstrated ability to support senior leaders in a fast-paced, highly confidential environment
- Biotechnology, Pharmaceutical, or life sciences experience preferred, experience supporting a legal function or familiarity with legal administrative processes is a plus
- Exceptional organizational and prioritization skills
- Strong verbal and written communication skills
- High emotional intelligence and relationship-building capability
- Proven ability to manage sensitive and confidential information
More about this role
Avalyn aims to transform the treatment paradigm for pulmonary fibrosis and other serious, rare respiratory diseases. The company is advancing optimized inhaled formulations of established antifibrotic medicines designed to deliver drug directly to the lungs, enhance local efficacy, and reduce systemic side effects. Avalyn’s AP01 program is an optimized inhaled formulation of pirfenidone currently being evaluated in MIST, a global Phase 2b clinical trial in patients with progressive pulmonary fibrosis (PPF). AP01 has demonstrated encouraging safety and clinical activity across Phase 1b and an ongoing, multi-year open-label extension trial, with long-term data supporting the potential to preserve lung function while improving tolerability relative to historical oral pirfenidone. Avalyn’s AP02 program is an optimized inhaled formulation of nintedanib currently being evaluated in AURA-IPF, a global Phase 2 clinical trial in patients with idiopathic pulmonary fibrosis (IPF). Avalyn is also advancing AP03, an inhaled fixed-dose combination of pirfenidone and nintedanib, designed to deliver multiple antifibrotic mechanisms through a single lung-targeted platform. By leveraging its...
Browse similar: Startup jobs · Boston